Status:

COMPLETED

Phaco vs. Phaco-ELT vs. Phaco-Trabectome 12m

Lead Sponsor:

University of Zurich

Conditions:

Glaucoma

Cataract

Eligibility:

All Genders

18+ years

Brief Summary

This study compares efficacy (i.e. IOP and hypotensive medications) of phaco alone vs. combined phaco plus excimer laser trabeculotomy vs. combined phaco plus trabectome.

Detailed Description

Glaucoma is one of the most common reasons for blindness. Usually an elevated drain resistance is the reason, while aqueous humor production is normal. Medical reduction of intraocular pressure (IOP) ...

Eligibility Criteria

Inclusion

  • Inclusion criteria:
  • All patients, which had Phaco, Phako/ELT, or Phaco-Trabectome from 01/2008 until 12/2011, where screened 12 month after surgery
  • Exclusion criteria:
  • IOP \>35 mmHg

Exclusion

    Key Trial Info

    Start Date :

    January 1 2009

    Trial Type :

    OBSERVATIONAL

    Allocation :

    ACTUAL

    End Date :

    December 31 2016

    Estimated Enrollment :

    245 Patients enrolled

    Trial Details

    Trial ID

    NCT01194310

    Start Date

    January 1 2009

    End Date

    December 31 2016

    Last Update

    July 13 2017

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    Zurich, Switzerland